Accumulating properties of NSC-631570

26^th World Cancer and Oncodiagnostics Conference

November 27-28, 2017 Dubai, UAE

Wassil Nowicky

Nowicky Pharma, Austria
Ukrainian Anti-Cancer Institute, Austria

Keynote: J Cancer Sci Ther

Abstract :

The preparation NSC-631570 (UKRAIN) is the very first preparation against cancer with a selective effect that means that in therapeutic dosage it kills only cancer cells leaving the healthy cells undamaged. For the invention of this preparation was used the factor that cancer cells are more negative charged than normal cells. For this purpose the Celandine alkaloid with a positive charge has been used thanks to which it accumulates in cancer cells very fast that is visible under the UV-light thanks to the auto-fluorescence. The anticancer preparation NSC-631570 has the ability to capsule cancer tumors, thanks to which the creation of new metastases is stopped. Besides, this ability makes the surgical removal of the tumors much easier. These abilities of the NSC-631570 have been confirmed by the 188 research works at 60 universities and research centers from 24 countries. To the NSC-631570 more than 300 scientific publications are dedicated and over 180 of them can be found on PubMed.

Biography :

Wassil Nowicky is the Director of Nowicky Pharma and President of the Ukrainian Anti-Cancer Institute, Vienna, Austria. He has completed his study at the Radiotechnical Faculty of the Technical University of Lviv, Ukraine with the end of 1955 with graduation to “Diplomingeniueur” in 1960 which title was nostrificated in Austria in 1975. He is the inventor of the anti-cancer preparation on basis of celandine alkaloids NSC-631570.